Board Change Update
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
Belfast and London, 29 October 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, today announces that following the announcement on 1 October 2024 and completion of the usual Nominated Adviser due diligence checks, Cheryl MacDiarmid is confirmed as having joined the board as a Non-Executive Director.
Additional information with regard to Cheryl MacDiarmid:
Cherly MacDiarmid (née Gaskin), age 56, is currently or has been a director of the following companies within the past five years:
| Current Directorships | Former Directorships |
Allergy Therapeutics Plc
Phivco UK Limited
ViiV Healthcare UK (NO.6) Limited
ViiV Healthcare UK (NO.3) Limited
ViiV Healthcare UK (NO.5) Limited
ViiV Healthcare Trading Services UK Limited
ViiV Healthcare UK (NO.4) Limited
ViiV Healthcare Overseas Limited
ViiV Healthcare UK (NO.7) Limited
ViiV Healthcare Finance Limited
ViiV Healthcare UK Limited
Phivco UK II Limited
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.